Exane Derivatives’s CRISPR Therapeutics CRSP Stock Holding History

Exane Derivatives’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.22K	Hold
2022 Q1	$1.25K	Hold
2021 Q4	$1.52K	Sell
2021 Q3	$103K	Buy
2021 Q2	$88.1K	Sell
2021 Q1	$80.8K	Buy